Dr. Alemozaffar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3430 E La Palma Ave
Anaheim, CA 92806Phone+1 714-644-7111
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2012 - 2014
- Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 2008 - 2012
- Brigham and Women's HospitalResidency, Surgery, 2007 - 2008
- David Geffen School of Medicine at UCLAClass of 2007
Certifications & Licensure
- CA State Medical License 2013 - 2027
- GA State Medical License 2014 - 2020
- MA State Medical License 2007 - 2012
- American Board of Urology Urology
Clinical Trials
- Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease Start of enrollment: 2017 Mar 01
Publications & Presentations
PubMed
- 9 citationsEfficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Ph...Vikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, Neal D Shore
The Journal of Urology. 2024-07-01 - 2 citationsIntegrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis.Carlos S Moreno, Cynthia L Winham, Mehrdad Alemozaffar, Emma R Klein, Ismaheel O Lawal
Cancers. 2023-11-30 - 31 citationsSurgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.Siamak Daneshmand, Clint Cary, Timothy Masterson, Lawrence Einhorn, Nabil Adra
Journal of Clinical Oncology. 2023-06-01
Press Mentions
- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Makes It Easier to See the Invisible in Cancer SurgeryDecember 17th, 2020
- Debating the True Benefit of Adjuvant TKIs in High-Risk RCCOctober 4th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: